Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kuragenx
- Development stage
- Preclinical
- Lead developer
- Pandorum Technologies
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
Kuragenx is a lead exosome-based therapeutic candidate developed by Pandorum Technologies. It is engineered using a proprietary platform to produce tunable, regenerative exosomes that reprogram pathological tissue states, specifically targeting inflammation and fibrosis. The therapy aims to promote tissue repair and regeneration by modulating the local tissue environment. Pandorum Technologies has established a global manufacturing strategy for Kuragenx, partnering with AGC Biologics for the U.S. and European markets and Nucelion Therapeutics (a subsidiary of Bharat Biotech) for the Asia-Pacific region. The development of Kuragenx is supported by an $18 million Series B financing round intended to advance its clinical programs and scale up global operations.
- Brand names
- Kuragenx
- Other names
- Kuragenx
Beyond the preview
Go deeper on Kuragenx.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kuragenx.